Keybanc maintains Vtex (NYSE:VTEX) with a Overweight and lowers the price target from $25 to $10.
Eli Lilly Q1 EPS $2.62 Beats $2.13 Estimate, Sales $7.81B Beat $6.68B Estimate
Eli Lilly (NYSE:LLY) reported quarterly earnings of $2.62 per share which beat the analyst consensus estimate of $2.13 by 23 percent. This is a 40.11 percent increase over earnings of $1.87 per share from the same period
